John G. Ullman & Associates’s Medtronic MDT Stock Holding History

John G. Ullman & Associates’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,756	Closed	-$268K	–	120
2016 Q4	$268K	Sell	3,756 -1,725	-31%	-$136K	0.06%	107
2016 Q3	$474K	Sell	5,481 -48,344	-90%	-$4.21M	0.1%	96
2016 Q2	$4.67M	Sell	53,825 -1,531	-3%	-$124K	0.96%	36
2016 Q1	$4.15M	Sell	55,356 -5,910	-10%	-$445K	0.97%	32
2015 Q4	$4.71M	Sell	61,266 -8,011	-12%	-$603K	1.04%	29
2015 Q3	$4.64M	Sell	69,277 -8,135	-11%	-$599K	1.1%	30
2015 Q2	$5.74M	Buy	+77,412	New	+$5.91M	1.08%	24
2015 Q1	–	Sell	-71,933	Closed	-$5.19M	–	146
2014 Q4	$5.19M	Sell	71,933 -1,250	-2%	-$86.8K	0.98%	30
2014 Q3	$4.53M	Sell	73,183 -1,900	-3%	-$121K	0.87%	33
2014 Q2	$4.79M	Sell	75,083 -2,006	-3%	-$122K	0.87%	32
2014 Q1	$4.74M	Sell	77,089 -3,600	-4%	-$210K	0.88%	34
2013 Q4	$4.63M	Sell	80,689 -1,400	-2%	-$79.4K	0.88%	33
2013 Q3	$4.37M	Sell	82,089 -2,961	-3%	-$159K	0.89%	33
2013 Q2	$4.38M	Buy	+85,050	New	+$4.2M	0.91%	35

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

John G. Ullman & Associates's MDT Position: Q1 2017 in Review

John G. Ullman & Associates sold out of Medtronic (MDT) in Q1 2017, closing a stake of 3,756 shares — an estimated $268K sold.

John G. Ullman & Associates first reported a position in MDT in Q2 2013 and held it in 14 quarters. The position peaked at $5.74M in Q2 2015. 1,283 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

John G. Ullman & Associates reported no remaining Medtronic position as of Q1 2017 after selling out during the quarter.
John G. Ullman & Associates sold 3,756 Medtronic shares in Q1 2017, an estimated $268K.
John G. Ullman & Associates first reported a position in Medtronic in Q2 2013 and held it in 14 quarters.
John G. Ullman & Associates's Medtronic position peaked at $5.74M in Q2 2015.
1,283 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on John G. Ullman & Associates's 13F filing for Q1 2017, filed 25 Apr 2017.